Insightful review explores alcohol-related liver cancer pathogenesis

While heavy drinking is a well-established risk factor for liver cancer, the specific mechanisms by which alcohol contributes to A-HCC remain unclear.

Supreme Court declines to review patent battle over inhalation powder Yutrepia

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 8, 2024

Harnessing artificial intelligence for infectious disease prevention

A new research review to be given at a pre-congress day for this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) will

February 28, 2024

Bayer expands Kerendia heart failure program to 15,000 patients as it plans to start three Phase III trials

Bayer is working on expanding the label for its chronic kidney disease drug Kerendia, announcing three new trials to investigate it as a treatment for

September 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.